Sienna Biopharmaceuticals Garners $12,000,000 Series A Financing

  • Feed Type
  • Date
    7/13/2016
  • Company Name
    Sienna Biopharmaceuticals
  • Mailing Address
    30721 Russell Ranch Road Westlake Village, CA 91362 USA
  • Company Description
    Sienna Biopharmaceuticals is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of medicine.
  • Website
    http://www.siennabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The additional investment proceeds are targeted to fund Sienna’s pharmaceutical research and advance its business development efforts. Sienna’s lead proprietary technology, Silver Plasmonic Therapy (SPT) has promising applications for acne and permanent hair removal. Clinical trials are already underway and the Company is evaluating additional potential indications.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Partner Fund Management
  • Venture Investor
    Undisclosed

Trending on Xconomy